Literature DB >> 17322953

The Brazilian Portuguese version of the Work Productivity and Activity Impairment: General Health (WPAI-GH) Questionnaire.

Rozana Mesquita Ciconelli1, Patrícia Coelho de Soárez, Clarissa Campos Guaragna Kowalski, Marcos Bosi Ferraz.   

Abstract

CONTEXT AND
OBJECTIVE: It is still difficult to measure work productivity losses caused by health problems. Despite the importance given to this issue over the last few years, most instruments for performing this task are available only in the English language. This study translated the Work Productivity and Activity Impairment _ General Health (WPAI-GH) Questionnaire into Brazilian Portuguese, adapted it cross-culturally and evaluated its reliability and validity. DESIGN AND
SETTING: Cross-sectional survey to test scale reliability and validity, at São Paulo Hospital and the clinic of the Rheumatology division of Universidade Federal de São Paulo-Escola Paulista de Medicina (Unifesp-EPM).
METHODS: Data were obtained from a survey that incorporated the WPAI-GH, short form-36 (SF-36) and some demographic questions. The questionnaires were administered by interview to 100 subjects.
RESULTS: Descriptive statistics was used to characterize the subjects. The intraclass correlation coefficient and Cronbach's alpha were used to assess the reliability and internal consistency of the instrument. Intraclass correlation coefficients from 0.79 to 0.90 indicated good reliability. Cronbach's alpha of 0.74 indicated good internal consistency. Pearson's correlation coefficient was used to assess validity. There were significant positive relationships between the WPAI-GH and SF-36.
CONCLUSION: The Brazilian Portuguese version of the WPAI-GH is a reliable and valid measurement tool and may be useful for those who seek to measure the impact on productivity of health problems among populations of Brazilian employees.

Mesh:

Year:  2006        PMID: 17322953     DOI: 10.1590/s1516-31802006000600005

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  12 in total

1.  Comparison of self-report and interview administration methods based on the Brazilian versions of the Western Ontario Rotator Cuff Index and Disabilities of the Arm, Shoulder and Hand Questionnaire in patients with rotator cuff disorders.

Authors:  Andréa Diniz Lopes; Ricardo de Vilar e Furtado; César Augusto da Silva; Liu Chiao Yi; Cristina Assumpção Malfatti; Silvana Antunes de Araújo
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

2.  Validity of the work productivity and activity impairment questionnaire--general health version in patients with rheumatoid arthritis.

Authors:  Wei Zhang; Nick Bansback; Annelies Boonen; Adam Young; Amitabh Singh; Aslam H Anis
Journal:  Arthritis Res Ther       Date:  2010-09-22       Impact factor: 5.156

3.  Translation into Brazilian Portuguese, cross-cultural adaptation and validation of the Stanford presenteeism scale-6 and work instability scale for ankylosing spondylitis.

Authors:  Renata Frauendorf; Marcelo de Medeiros Pinheiro; Rozana Mesquita Ciconelli
Journal:  Clin Rheumatol       Date:  2013-11-13       Impact factor: 2.980

4.  Validation of the Brazilian-Portuguese version of the Gesture Behavior Test for patients with non-specific chronic low back pain.

Authors:  Ricardo Furtado; Anamaria Jones; Rita N V Furtado; Fábio Jennings; Jamil Natour
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

5.  Study of endothelial function response to exercise training in hypertensive individuals (SEFRET): study protocol for a randomized controlled trial.

Authors:  Marinei Lopes Pedralli; Gustavo Waclawovsky; Augusto Camacho; Melissa Medeiros Markoski; Iran Castro; Alexandre Machado Lehnen
Journal:  Trials       Date:  2016-02-13       Impact factor: 2.279

6.  Work ability and productivity in patients with diabetic foot.

Authors:  Helga Dos Santos Cabeceira; Diba Maria Sebba Tosta de Souza; Yara Juliano; Daniela Francescato Veiga
Journal:  Clinics (Sao Paulo)       Date:  2019-03-25       Impact factor: 2.365

7.  Humanistic and Economic Impact of Moderate to Severe Plaque Psoriasis in Brazil.

Authors:  Nilcéia Lopes; Leticia L S Dias; Luna Azulay-Abulafia; Luiza K M Oyafuso; Maria Victoria Suarez; Lincoln Fabricio; Clarice Marie Kobata; Tania Cestari; Bernardo Gontijo; Cid Y Sabbag; João R Antonio; Ricardo Romiti; Patricia C Pertel
Journal:  Adv Ther       Date:  2019-08-20       Impact factor: 3.845

8.  Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.

Authors:  Rogerio S Parra; Julio M F Chebli; Heda M B S Amarante; Cristina Flores; Jose M L Parente; Odery Ramos; Milene Fernandes; Jose J R Rocha; Marley R Feitosa; Omar Feres; Antonio S Scotton; Rodrigo B Nones; Murilo M Lima; Cyrla Zaltman; Carolina D Goncalves; Isabella M Guimaraes; Genoile O Santana; Ligia Y Sassaki; Rogerio S Hossne; Mauro Bafutto; Roberto L K Junior; Mikaell A G Faria; Sender J Miszputen; Tarcia N F Gomes; Wilson R Catapani; Anderson A Faria; Stella C S Souza; Rosana F Caratin; Juliana T Senra; Maria L A Ferrari
Journal:  World J Gastroenterol       Date:  2019-10-14       Impact factor: 5.742

9.  Effects of exercise on kidney function among non-diabetic patients with hypertension and renal disease: randomized controlled trial.

Authors:  Franklin C Barcellos; Iná S Santos; Grégore Iven Mielke; Fabrício B del Vecchio; Pedro C Hallal
Journal:  BMC Nephrol       Date:  2012-08-28       Impact factor: 2.388

10.  Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C.

Authors:  Lucas Pereira Jorge de Medeiros; Mario Barreto Correa Lima; Marcia Maria Amêndola Pires; Alessandra Mendonça Almeida Maciel; Renata Barboza Vianna Medeiros; Mariana Dermínio Donadel; Isabela Martins Becattini Pereira; Fábio Marchon Leão; Luiz Eduardo Amorim Correa Lima Pires; Helio Rzetelna; Carlos Eduardo Brandão-Mello
Journal:  Osong Public Health Res Perspect       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.